HNW / UHNW
Investable assets $1M+ through $30M+. Private-banking, wealth management, family office audiences.
HNW, UHNW, C-suite, niche clinicians, rare-disease patients, regulated professionals. When incidence is below 1% and the panel doesn’t exist, we go build it.
Every cohort is continuously refreshed, routinely re-verified, and permission-managed.
Investable assets $1M+ through $30M+. Private-banking, wealth management, family office audiences.
CEOs, CFOs, CMOs at companies $50M+ revenue — verified at the registrar level.
Verified diagnosis, patient-advocacy partnerships, IRB-appropriate consent.
Compliance officers, MLROs, radiation safety, FDA QA heads.
Senior civil servants, elected officials, policy advisors.
Named-account, industry-specific, territory-specific — built to your brief.
Verification is not a one-off gate — it’s a rhythm. Here is exactly what happens before a respondent is ever invited into your survey.
Where appropriate: government ID, proof of address, employer.
HNW/UHNW verified via banking partner or self-attested with audit.
Rare-disease via patient-group partnerships, not open recruitment.
C-suite verified via Companies House, SEC filings or equivalent.
Sensitive populations sign study-specific consent every engagement.
Identifiable data tokenised end-to-end by default.
Tell us the audience profile, geography, and sample requirements. We'll come back within 2 hours with feasibility, timing, and a quote.